Nuevos fármacos en el tratamiento de la incontinencia urinaria

Robles-Garcia, J.E. (José Enrique); Zudaire-Bergera, J.J. (Juan Javier); Rosell, D. (David); Berian-Polo, J.M. (José María)

Autor(es):

Robles-Garcia, J.E. (José Enrique)

Zudaire-Bergera, J.J. (Juan Javier)

Rosell, D. (David)

Berian-Polo, J.M. (José María)

Palabras clave :

Incontinencia urinaria de esfuerzo
Duloxetina
Vejiga hiperactiva
Solifenacina

Fecha de publicación :

2005

Editorial :

Ediciones Universidad de Navarra

ISSN :

0556-6177

Cita:

Robles García JE, Zudaire Bergera JJ, Rosell Costa D, Berián Polo JM. Nuevos fármacos en el tratamiento de la incontinencia urinaria . Rev Med Univ Navarra. 2004 Oct-Dec;48(4):43-9.

Resumen

Several classes of drugs have been investigated for their efficacy in treating overactive bladder syndrome (OAB) and stress urinary incontinence (SUI). Surgery and behavioral therapies are currently the mainstay of treating SUI. However, results are also being made available about a new oral medication, Duloxetine, which appears to be clinically safe and effective for the treatment of SUI. On the other hand, a new muscarinic receptor antagonist, Solifenacin, has been shown in clinical trials to be clinically effective, safe and well tolerated for treating OAB

URI :

https://hdl.handle.net/10171/35415

Aparece en las colecciones:

DA - CUN - Urología - Artículos de revista

Ficheros en este ítem: